Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
T Stamp A | IDAI | 20. mai 2024 | 0.69 | +0.72 |
T-Mobile US | TMUS | 20. mai 2024 | 163.90 | -0.06 |
T. Rowe Price Blue Chip Growth ETF | TCHP | 20. mai 2024 | 36.34 | +0.47 |
T. Rowe Price Dividend Growth ETF | TDVG | 20. mai 2024 | 38.44 | -0.31 |
T. Rowe Price Equity Income ETF | TEQI | 20. mai 2024 | 40.03 | -0.42 |
T. Rowe Price Group | TROW | 20. mai 2024 | 117.13 | +0.32 |
T. Rowe Price Growth Stock ETF | TGRW | 20. mai 2024 | 34.93 | +0.39 |
T2 Biosystems | TTOO | 20. mai 2024 | 6.06 | +7.45 |
Taboola.com | TBLA | 20. mai 2024 | 4.26 | -1.39 |
Tactile Systems Technology | TCMD | 20. mai 2024 | 13.65 | -0.58 |
Taitron Components A | TAIT | 20. mai 2024 | 2.92 | -1.68 |
Taiwan Fund | TWN | 20. mai 2024 | 39.86 | -0.33 |
Taiwan Index MSCI Ishares | EWT | 20. mai 2024 | 50.83 | -0.29 |
Taiwan Semiconductor Manufacturing ADR | TSM | 20. mai 2024 | 153.55 | +1.23 |
Take-Two Interactive Software | TTWO | 20. mai 2024 | 150.90 | +2.07 |
Takeda Pharmaceutical ADR | TAK | 20. mai 2024 | 13.28 | +0.45 |
TAL Education Group ADR | TAL | 20. mai 2024 | 12.62 | -2.40 |
Talis Biomedical | TLIS | 20. mai 2024 | 8.70 | -3.12 |
Talkspace | TALK | 20. mai 2024 | 2.80 | +1.82 |
Talos Energy | TALO | 20. mai 2024 | 12.25 | +0.91 |
Talphera | TLPH | 20. mai 2024 | 1.08 | 0.00 |
Tandem Diabetes Care | TNDM | 20. mai 2024 | 47.23 | -0.15 |
Tanger | SKT | 20. mai 2024 | 27.70 | -0.14 |
Tango Therapeutics | TNGX | 20. mai 2024 | 7.67 | +1.99 |
Tantech | TANH | 20. mai 2024 | 0.97 | +47.64 |
Taoping | TAOP | 20. mai 2024 | 0.81 | +2.00 |
Tapestry | TPR | 20. mai 2024 | 42.46 | +0.33 |
Targa Resources | TRGP | 20. mai 2024 | 117.55 | -0.10 |
Target | TGT | 20. mai 2024 | 156.71 | -2.14 |
Target Global Acquisition I A | TGAA | 20. mai 2024 | 11.30 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.